Xiao Zhi Selected Research

Drug Therapy (Chemotherapy)

1/2020	Genome-wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis.
11/2019	miR-223 overexpression inhibits doxorubicin-induced autophagy by targeting FOXO3a and reverses chemoresistance in hepatocellular carcinoma cells.
3/2016	Regulation of Multi-drug Resistance in hepatocellular carcinoma cells is TRPC6/Calcium Dependent.
4/2015	Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation.
12/2014	Inhibition of protein phosphatase 2A sensitizes pancreatic cancer to chemotherapy by increasing drug perfusion via HIF-1α-VEGF mediated angiogenesis.
8/2014	Inhibition of protein phosphatase 2A enhances cytotoxicity and accessibility of chemotherapeutic drugs to hepatocellular carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiao Zhi Research Topics

Disease

25	Neoplasms (Cancer) 07/2022 - 12/2012
11	Stomach Neoplasms (Stomach Cancer) 06/2018 - 01/2011
8	Hepatocellular Carcinoma (Hepatoma) 11/2019 - 12/2012
5	Hypoxia (Hypoxemia) 07/2022 - 12/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 12/2014
3	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2015
2	Nervous System Diseases (Neurological Disorders) 12/2021 - 01/2021
2	Adenocarcinoma 01/2019 - 09/2015
2	Lung Neoplasms (Lung Cancer) 01/2018 - 01/2016
2	Disease Progression 01/2017 - 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 07/2022
1	Triple Negative Breast Neoplasms 01/2022
1	COVID-19 12/2021
1	Stroke (Strokes) 01/2021
1	Ischemic Stroke 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Circulating Neoplastic Cells 01/2018
1	Teratoma (Teratoid Tumor) 01/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017

Drug/Important Bio-Agent (IBA)

9	GoldIBA 09/2021 - 05/2013
9	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 12/2012
8	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 08/2014
4	Therapeutic UsesIBA 12/2021 - 09/2015
4	MicroRNAs (MicroRNA)IBA 06/2018 - 01/2015
3	Peptides (Polypeptides)IBA 01/2022 - 01/2018
3	phytochlorinIBA 10/2018 - 01/2018
3	CytokinesIBA 01/2018 - 06/2015
2	Small Interfering RNA (siRNA)IBA 07/2022 - 01/2016
2	AntibodiesIBA 12/2021 - 12/2015
2	AntigensIBA 01/2020 - 12/2015
2	CarbohydratesIBA 01/2020 - 12/2015
2	degrasynIBA 11/2018 - 06/2015
2	Gemcitabine FDA Link 11/2018 - 09/2015
2	Photosensitizing Agents (Photosensitizers)IBA 10/2018 - 01/2018
2	SilverIBA 06/2018 - 05/2013
2	Biological ProductsIBA 01/2018 - 03/2016
2	OSI 027IBA 01/2017 - 09/2015
2	Silicon Dioxide (Silica)FDA LinkGeneric 12/2016 - 05/2013
2	LB100IBA 12/2014 - 08/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 08/2014
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 12/2014 - 08/2014
1	Antisense RNA (Anti-Sense RNA)IBA 07/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2022
1	LTX-315IBA 01/2022
1	ElementsIBA 01/2022
1	LactoferrinIBA 01/2022
1	LigandsIBA 01/2022
1	Long Noncoding RNAIBA 01/2022
1	Viral RNAIBA 12/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	GlypicansIBA 09/2021
1	transgelinIBA 01/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	TFXIBA 01/2020
1	Circulating Tumor DNAIBA 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	Ubiquitin-Specific ProteasesIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 06/2018
1	aconitic anhydrideIBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2017
1	IonsIBA 01/2017
1	GadoliniumIBA 01/2017
1	Calcium Carbonate (Limestone)FDA Link 01/2017
1	Contrast MediaIBA 01/2017
1	Interleukin-2 (IL2)IBA 12/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	Interleukin-12 (IL 12)IBA 12/2016
1	Interleukin-4 (Interleukin 4)IBA 12/2016
1	Interleukin-1 (Interleukin 1)IBA 12/2016
1	TRPC6 Cation ChannelIBA 03/2016
1	CalciumIBA 03/2016
1	Volatile Organic CompoundsIBA 01/2016
1	AMP-Activated Protein KinasesIBA 01/2016
1	Cadherins (E-Cadherin)IBA 01/2016
1	4-sulfophenylmethallyl ether (SPME)IBA 01/2016
1	VimentinIBA 01/2016
1	Carcinoembryonic AntigenIBA 12/2015
1	EnzymesIBA 12/2015
1	Helicobacter pylori cagA proteinIBA 12/2015
1	Pepsinogen A (Pepsinogen)IBA 12/2015
1	ImmunosorbentsIBA 12/2015
1	VaccinesIBA 06/2015
1	Combined VaccinesIBA 06/2015
1	CateninsIBA 04/2015
1	salinomycinIBA 04/2015
1	AlloysIBA 01/2014
1	Serum-Free Culture MediaIBA 01/2014

Therapy/Procedure

11	Therapeutics 11/2019 - 12/2012
6	Drug Therapy (Chemotherapy) 01/2020 - 08/2014
5	Immunotherapy 01/2022 - 06/2015
5	Precision Medicine 10/2018 - 01/2015
3	Lasers (Laser) 10/2018 - 02/2016
3	Photochemotherapy (Photodynamic Therapy) 01/2018 - 01/2016
3	Photothermal Therapy 01/2017 - 02/2016
1	Liver Transplantation 01/2017
1	Secondary Prevention 06/2015
1	Gastrectomy 01/2015